Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Midcap Financial
AddedFeb 13, 2024
UpdatedJun 28, 2026
Midcap Financial

Midcap Financial

Acquired

MidCap Financial, a specialty finance firm managed by Apollo Capital, provides flexible, cost-effective senior debt solutions to diverse industries.

Location
Bethesda, MD, US
Founded
2008
Firm
Compare
Portfolio
Fundraising
Employees
Website

MidCap Financial is a specialty finance firm managed by Apollo Capital, focusing on providing senior debt solutions to middle-market companies across various industries. The firm offers a wide range of financial products designed to support growth and manage working capital. Typical investment rounds include post-IPO debt, debt financing, and various series funding rounds, with commitments exceeding $3 billion under management.

Notable portfolio companies include BioCryst Pharmaceuticals, LendingPoint, and Unchained Labs. MidCap Financial's key partners leverage their extensive experience and affiliations with Apollo Capital to deliver flexible and cost-effective financing solutions. The firm’s investment philosophy centers on partnering with management teams and sponsors to create tailored debt solutions, providing significant value-add services such as strategic guidance and operational support to its portfolio companies.

Midcap Financial - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments29
Current Portfolio Count26
Total Portfolio Exits1

Top Investment Stages

Post Ipo Debt13 (50.0%)
Debt Financing10 (38.5%)
Late Stage Private1 (3.8%)
Series A1 (3.8%)
Series B1 (3.8%)

Stage Mix

Post Ipo Debt 50%Debt Financing 38%Late Stage Private 4%Series A 4%Series B 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Strata Skin Sciences logo

Strata Skin Sciences

Marco logo

Marco

Apyx Medical logo

Apyx Medical

ViewRay logo

ViewRay

Tela Bio logo

Tela Bio

Forge Biologics logo

Forge Biologics

Aterian logo

Aterian

Upstack logo

Upstack

Unchained Labs logo

Unchained Labs

Xtant Medical Holdings logo

Xtant Medical Holdings

LendingPoint logo

LendingPoint

Arboretum Investment Advisors logo

Arboretum Investment Advisors

Sight Sciences logo

Sight Sciences

BioCryst Pharmaceuticals logo

BioCryst Pharmaceuticals

Kashable logo

Kashable

The Credit Junction logo

The Credit Junction

ZPower logo

ZPower

Partner Therapeutics logo

Partner Therapeutics

Dnanexus logo

Dnanexus

Sarepta Therapeutics logo

Sarepta Therapeutics

Elutia logo

Elutia

Fundation Group logo

Fundation Group

Intarcia Therapeutics logo

Intarcia Therapeutics

Spectra7 Microsystems logo

Spectra7 Microsystems

Staffing 360 Solutions logo

Staffing 360 Solutions

Midcap Financial - Classification

Also Known As
  • Midcap Financial Services LLC
NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions
Show 14 more industry codes
NAICS
  • 523100Securities and Commodity Contracts Intermediation and Brokerage
  • 523150Investment Banking and Securities Intermediation
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6100Nondepository Credit Institutions
  • 6210Security Brokers, Dealers, And Flotation Companies
  • 6211Security Brokers, Dealers, And Flotation Companies
  • 5000Wholesale Trade-durable Goods
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end